Head and Neck Cancer
3 stories
-
healthHPV Vaccine Significantly Cuts Cancer Risk in Young Males, Study Finds
New international study reveals the 9-valent HPV vaccine reduces cancer risk by 46% in males aged 9-26, supporting gender-neutral vaccination programs.
-
healthHPV Vaccine: Your Shield Against Common Cancers
Understand why the HPV vaccine is crucial for preventing various cancers, including cervical, head, and neck cancers. Learn who should get vaccinated.
-
healthHead and Neck Cancer: Immunotherapy and Oncolytic Viruses Reshape Treatment
Explore the cutting edge of head and neck cancer treatment, focusing on immunotherapy and oncolytic viruses, with insights from leading oncologist Kevin Harrington.